A global goal aimed to halve anemia in women by 2025. By 2023, not one of 192 economies had cut its rate in half.

In May 2012, all 194 WHO member states endorsed resolution WHA65.6, which set six global nutrition targets for 2025. Target 2 was a collective goal: a 50% reduction in anemia among women of reproductive age — defined as hemoglobin below 12 g/dL for non-pregnant and below 11 g/dL for pregnant women ages 15–49 — measured against 2012 levels. It was a target for global prevalence, not a per-country quota; countries set national targets aligned to it. The 2025 deadline has passed; the latest WHO country estimates run through 2023. WHO's Global Health Observatory publishes modeled annual prevalence estimates for this exact population; the World Bank carries the series as SH.ANM.ALLW.ZS. Every country anemia-prevalence figure in this piece is a WHO modeled estimate from that series — modeled, not directly measured. Of the World Bank's 217 economies, 192 have estimates for both the 2012 baseline year and 2023 — the most recent year available; 25 lack one or both. Measured country by country against the 50% benchmark, not one ^mmodeled of the 192 had cut its own rate in half by 2023. The Philippines recorded the deepest cut: 18.7% to 12.0% ^mmodeled, a 35.8% reduction — the best of the 192 economies with both-year data, and still about 14 percentage points short of a halving. Sri Lanka was next at −18.0%. Every other economy either improved by less or moved in the wrong direction. 152 of 192 economies (79%) ^mmodeled recorded a higher anemia prevalence in 2023 than in 2012. The unweighted median across the 192 — a Claridas aggregation of WHO country estimates — rose from 22.0% to 25.5% ^mmodeled. WHO's own population-weighted global prevalence, the metric the target actually names, has been roughly flat to rising rather than the 50% cut the goal sought ^mmodeled.

The following is analysis, not fact. The benchmark was a single global 50% cut. Read country by country against it, the 192-economy panel — every income tier, every region — shows none reaching it by 2023. Among the 53 economies that entered 2012 with the heaviest burden — anemia rates above 30% — not one ^mmodeled recorded a 50% reduction by 2023. The median change in that group was 0.0% ^mmodeled: flat, not declining. Twenty-six of those 53 worsened. India — at a 53.7% modeled anemia rate among its women of reproductive age — moved from 50.1% to 53.7% ^mmodeled, a 7.2% increase; halving its own rate would have meant reaching 25.1%, leaving it 28.6 percentage points above a halved rate. Afghanistan moved from 36.5% to 45.4% ^mmodeled, the sharpest deterioration among high-burden economies. Among the high-burden group, Gambia (−13.2%), Senegal (−13.1%), Nigeria (−12.9%), and Ghana (−12.8%) ^mmodeled led the improvers — each a genuine decline over the period, and each achieving roughly one-quarter of the 50% benchmark. The pattern across the full panel points to a gap between the pace the global target assumed and what the underlying nutrition systems delivered [speculative — the data shows the outcome, not the mechanism].

Large increases in high-income economies — Canada's modeled rate rose from 7.7% to 14.0%, France's from 8.0% to 13.1%, Germany's from 9.1% to 14.0%, Australia's from 6.9% to 11.1% ^mmodeled — warrant caution. WHO substantially revised its anemia estimation methodology in 2021, and the retrospective 2012 values now in the series may differ from the baseline estimates that existed when WHA65.6 was adopted. If the revision lowered historical baselines for some economies and raised current-year estimates, the observed increase in high-income countries may be partly a measurement artifact. The headline finding — none of the 192 cut its rate in half by 2023 — is unaffected: no high-income economy with single-digit baseline anemia halved its rate, which from those baselines would have required reaching 3–5%. But the 152-of-192 count includes these revisions; the fraction of economies that genuinely deteriorated is likely lower ^sspeculative. Proponents of global nutrition targets argue that without the 2012 resolution, political and financial attention to anemia would have been further reduced — and that the Philippines' 30%+ reduction suggests such a cut is achievable under concentrated intervention ^sspeculative.

From India's position, the gap between the goal and the outcome is especially large in absolute terms. With a 2023 modeled rate of 53.7% across an estimated 350 million women of reproductive age (UN population data) — roughly 190 million affected ^mmodeled — India carries a large absolute burden. A policymaker in New Delhi would likely point to the structural scale of India's anemia programs — iron supplementation, deworming, and dietary diversification across 1.4 billion people — as evidence that the 2025 timeline was insufficient for a problem rooted in diet, healthcare access, and food systems that take decades to shift [speculative — the WHO data shows the gap, not its cause].